Aspirin Sales

Aspirin Sales Market Outlook

The global aspirin sales market is projected to reach approximately USD 1.5 billion by 2025, with a compound annual growth rate (CAGR) of 4.5% from 2023 to 2025. The increasing prevalence of cardiovascular diseases and the growing awareness about the benefits of aspirin in pain relief are key factors fueling the growth of this market. Additionally, the rise in self-medication trends and the expanding range of applications for aspirin, including its anti-inflammatory effects, are driving demand across various demographics. Furthermore, advancements in drug formulation, such as the development of enteric-coated and buffered aspirin, are enhancing the market's competitive landscape. The rise of e-commerce platforms is also expected to bolster sales, providing consumers with convenient access to aspirin products.

Growth Factor of the Market

Several growth factors are contributing to the expansion of the aspirin sales market. One of the most significant drivers is the increasing incidence of chronic diseases, particularly cardiovascular conditions, which necessitate long-term use of aspirin for prevention and treatment. Concurrently, the global aging population is more susceptible to conditions that warrant aspirin use, thus increasing market demand. Public health campaigns promoting aspirin’s role in reducing the risk of heart attacks and strokes are further enhancing market growth. Additionally, the growing trend of preventive healthcare is leading consumers to seek out medications that can proactively manage health issues. Furthermore, the expanding online retail sector offers a convenient platform for purchasing aspirin, particularly among younger consumers who prefer online shopping for health-related products.

Key Highlights of the Market

• The aspirin sales market is expected to grow steadily with a CAGR of 4.5% through 2025.
• Increasing incidence of cardiovascular diseases is a significant driver of market growth.
• Self-medication is trending upwards, contributing to increased aspirin usage.
• Innovative product formulations, such as buffered and enteric-coated aspirin, are enhancing consumer options.
• The online retail segment is rapidly expanding, providing increased accessibility to aspirin products.

By Product Type

Regular Aspirin:

Regular aspirin remains one of the most commonly used forms due to its effectiveness and affordability. It is primarily employed for pain relief and anti-inflammatory purposes. Healthcare professionals often recommend regular aspirin for conditions such as headaches, muscle aches, and arthritis pain. The simplicity of its formulation allows for widespread availability, contributing to its sustained popularity. Moreover, regular aspirin is often used in low doses as a preventative measure against cardiovascular events, making it a staple in many medicine cabinets worldwide. As a result, it holds a significant share of the market and continues to be a preferred choice for consumers seeking a reliable over-the-counter medication.

Enteric-coated Aspirin:

Enteric-coated aspirin is designed to dissolve in the intestine rather than the stomach, reducing the risk of gastrointestinal irritation, a common side effect of regular aspirin. This formulation has gained traction among consumers who are sensitive to traditional aspirin's side effects. Enteric-coated aspirin is particularly beneficial for individuals requiring long-term therapy, as it enhances patient compliance. The growing awareness of gastrointestinal complications associated with non-steroidal anti-inflammatory drugs (NSAIDs) has led to increased demand for enteric-coated options, positioning this product type as a niche yet significant segment of the market. Additionally, healthcare providers often recommend enteric-coated aspirin for patients with a history of stomach ulcers or gastrointestinal distress, further solidifying its market presence.

Buffered Aspirin:

Buffered aspirin combines aspirin with antacids to neutralize stomach acidity, mitigating the irritating effects associated with regular aspirin. This formulation is particularly advantageous for individuals who experience gastric discomfort or acid reflux when taking traditional aspirin. Buffered aspirin appeals to a demographic seeking effective pain relief while minimizing gastrointestinal side effects. The dual-action approach provides a compelling value proposition, particularly for patients requiring consistent pain management or anti-inflammatory treatment. As awareness of the benefits of buffered formulations increases, this segment is expected to capture a larger share of the aspirin sales market, especially among older adults and those with pre-existing gastrointestinal conditions.

Low-dose Aspirin:

Low-dose aspirin has gained prominence as a preventive measure against cardiovascular diseases, particularly among individuals with risk factors such as hypertension or high cholesterol. The American Heart Association recommends low-dose aspirin therapy for certain populations, which has significantly bolstered its use. This product type is often marketed for its heart-protective benefits, making it a popular choice among health-conscious consumers. The increase in health awareness and preventive healthcare strategies has resulted in a growing demand for low-dose aspirin, particularly among older adults. Pharmaceutical companies are actively promoting low-dose options, further solidifying their role in the aspirin sales market.

Chewable Aspirin:

Chewable aspirin has carved out a niche market, particularly for pediatric use and among adults who prefer a more palatable option. This formulation allows for quick absorption and is often recommended for use during acute pain episodes, such as headaches or migraines. Chewable aspirin is particularly appealing to younger consumers and those who have difficulty swallowing pills. The convenience and taste of chewable options make them an attractive alternative, especially for parents seeking effective medication for their children. As the demand for convenient and easy-to-administer medications increases, the chewable aspirin segment is poised for growth, appealing to a broader consumer base.

By Application

Pain Relief:

Pain relief is one of the primary applications of aspirin, making it a household name in the over-the-counter medication market. Aspirin is commonly used to alleviate mild to moderate pain, including headaches, toothaches, menstrual cramps, and muscle soreness. Its effectiveness as an analgesic is well-documented, and it remains a go-to choice for consumers seeking fast relief from daily discomfort. In addition to its analgesic properties, aspirin also possesses anti-inflammatory effects that enhance its pain-relieving capabilities, particularly for conditions such as arthritis. As awareness of its efficacy grows, the pain relief segment is expected to remain a dominant force in the aspirin sales market.

Anti-inflammatory:

Aspirin’s anti-inflammatory properties have made it a significant player in managing inflammatory conditions. It is commonly prescribed for conditions such as rheumatoid arthritis and osteoarthritis, where inflammation plays a central role in symptomatology. The ability of aspirin to reduce inflammation and associated pain has made it a critical component of treatment regimens for chronic inflammatory diseases. As the prevalence of such conditions rises, driven by lifestyle factors and an aging population, the demand for aspirin as an anti-inflammatory agent is expected to grow. This segment not only includes over-the-counter products but also prescription formulations that cater to more severe inflammatory disorders.

Cardiovascular Protection:

The role of aspirin in cardiovascular protection has been one of the most significant contributions to its market appeal. Low-dose aspirin therapy is widely recommended for individuals at risk of heart disease, as it helps prevent blood clots, reducing the likelihood of heart attacks and strokes. The endorsement of aspirin by medical professionals and health organizations has led to increased consumer awareness and usage, particularly among older adults. As the global population ages and the prevalence of cardiovascular diseases increases, the cardiovascular protection segment is expected to experience robust growth. Public health initiatives aimed at educating individuals about heart health will further drive demand for aspirin in this application area.

Fever Reduction:

Aspirin is also utilized for its antipyretic properties, providing effective relief from fever. While acetaminophen and ibuprofen have traditionally dominated the fever-reducing market, aspirin remains a viable option due to its effectiveness and long-standing presence in the healthcare landscape. Its use for fever reduction, particularly in adult populations, continues to maintain a steady demand. However, it is essential to note that aspirin is not recommended for fever management in children, particularly because of the risk of Reye's syndrome. Despite this limitation, the fever reduction application still represents a significant portion of the overall aspirin sales market.

Others:

This category encompasses various applications, including but not limited to, its role in preventing certain cancers, particularly colorectal cancer, and its use in treating other specific medical conditions. Research into the potential benefits of aspirin in cancer prevention has garnered attention, leading to increased interest in its broader health applications. Aspirin's multifunctionality has opened new avenues for usage, thus expanding its market reach. As more studies emerge highlighting these alternative applications, it is likely that the demand for aspirin will continue to diversify, thereby enhancing its overall market presence and driving future sales growth.

By Distribution Channel

Pharmacies:

Pharmacies remain the most significant distribution channel for aspirin sales, providing consumers with immediate access to this essential medication. Both chain and independent pharmacies carry a wide range of aspirin products, catering to varying consumer needs. The convenience of purchasing aspirin at pharmacies, coupled with the availability of pharmacist consultations, enhances consumer confidence in selecting the right product for their needs. Additionally, pharmacies often run promotions and discounts, which can further drive sales. The accessibility and reliability of pharmacies as a distribution channel ensure that they will continue to play a crucial role in the aspirin sales market.

Online Retailers:

The rise of e-commerce has dramatically transformed the way consumers purchase aspirin, with online retailers gaining a significant foothold in the market. The convenience of buying medications from home and the ability to compare products and prices easily contribute to the growing popularity of online shopping for aspirin. Many consumers appreciate the discreet nature of purchasing health-related products online. Additionally, online platforms often offer a broader selection of aspirin products, including specialized formulations that may not be available in local pharmacies. As technology continues to evolve, and with the increasing trend towards digital purchasing, online retailers are expected to capture an ever-increasing share of the aspirin sales market.

Hospitals & Clinics:

Hospitals and clinics are essential distribution channels for aspirin, particularly for patients who require immediate medical attention. In hospital settings, aspirin is frequently used in emergency departments for acute management of cardiovascular events. Furthermore, physicians often prescribe aspirin as part of treatment plans for various conditions, leading to sales in clinical environments. While hospital and clinical purchases may not be as frequent as retail purchases, the volume of aspirin used in these settings, especially for preventive healthcare, underscores their importance. This segment will continue to be relevant as healthcare providers increasingly recognize the value of aspirin in patient care.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets have become an increasingly popular channel for aspirin sales, providing consumers with convenient access to a variety of health products during their regular shopping trips. The wide aisles and extensive product offerings enable consumers to find aspirin alongside other household essentials. Supermarkets often engage in promotional strategies, such as discounts and bundling offers, which can significantly boost sales. The accessibility of aspirin in supermarkets makes it an attractive option for consumers who prefer to buy multiple items in one place. As the trend towards one-stop shopping continues, the supermarkets/hypermarkets segment is expected to maintain a robust presence in the aspirin sales market.

Others:

This category includes various alternative distribution channels, such as specialty health stores, convenience stores, and vending machines. Although these outlets may not account for a significant portion of total sales, they provide additional accessibility and convenience for consumers. Specialty health stores may offer a curated selection of aspirin products, appealing to health-conscious consumers seeking specific formulations. Convenience stores provide quick access to aspirin, particularly for individuals who may need immediate relief. As consumer preferences evolve, the importance of diverse distribution channels will continue to grow, allowing aspirin to reach a broader audience.

By Ingredient Type

Acetylsalicylic Acid:

Acetylsalicylic acid is the primary active ingredient in aspirin, known for its effectiveness in providing pain relief, anti-inflammatory effects, and cardiovascular protection. This ingredient is responsible for the therapeutic benefits associated with aspirin, making it essential in any aspirin formulation. It works by inhibiting enzymes involved in the inflammatory process and blocking pain pathways in the brain. The use of acetylsalicylic acid in different formulations, including regular, buffered, and enteric-coated aspirin, allows for a variety of consumer options based on individual health needs and preferences. The consistent demand for acetylsalicylic acid underscores its significance in the aspirin sales market.

Inactive Ingredients:

Inactive ingredients play a crucial role in the formulation of aspirin products, influencing their stability, absorption, and overall effectiveness. These ingredients may include binders, fillers, and coatings that enhance the production and delivery of aspirin. For example, enteric coatings are designed to protect the active ingredient from stomach acid, ensuring its release in the intestine. Additionally, inactive ingredients can affect the taste and texture of products, making them more palatable for consumers. As innovations in pharmaceutical manufacturing continue to evolve, the inclusion of specialized inactive ingredients will become increasingly important, allowing for the development of new and improved aspirin formulations that cater to diverse consumer preferences.

By Region

North America is currently the largest market for aspirin sales, accounting for approximately 35% of the global market share. The high prevalence of cardiovascular diseases and the growing awareness of preventive healthcare contribute significantly to this region's demand for aspirin. The United States, in particular, is a major player, with numerous over-the-counter options available to consumers. The North American market is projected to grow at a CAGR of 4.5%, driven by increased self-medication trends and public health initiatives promoting heart health. Additionally, the shift toward online retailing has made aspirin more accessible to consumers across the region, further supporting market expansion.

Europe follows closely, holding about 30% of the global aspirin sales market. The awareness regarding the health benefits of aspirin, particularly for cardiovascular protection, is driving growth in several European countries. Countries such as Germany and the United Kingdom are significant contributors to the market, supported by robust healthcare systems and a focus on preventive medicine. The European market is expected to witness steady growth, with an increasing emphasis on researching new applications for aspirin in disease prevention and management. Furthermore, the ongoing development of innovative formulations, such as enteric-coated aspirin, is likely to boost sales in this region.

Opportunities

The aspirin sales market offers several opportunities for growth and expansion, particularly in emerging markets. As economies develop and healthcare infrastructure improves, there is a growing potential for increased awareness about the benefits of aspirin. Countries in Asia Pacific and Latin America are experiencing a rise in lifestyle-related diseases, such as obesity and diabetes, which are often linked to cardiovascular conditions. As a result, there is an increasing need for preventive healthcare solutions, including aspirin therapy. By focusing on education and outreach efforts in these regions, companies can tap into a vast consumer base seeking effective and affordable health solutions, thus driving sales growth in the aspirin market.

Another significant opportunity lies in the development of new formulations and delivery methods for aspirin. With advancements in pharmaceutical technology, companies can create innovative products that address specific consumer needs, such as taste-masking chewable aspirin for children or specialized formulas for patients with gastrointestinal sensitivities. Additionally, there is potential for research into the efficacy of aspirin in new therapeutic areas, such as cancer prevention and management. By diversifying product offerings and exploring novel applications, companies can enhance their competitive edge and capture a larger share of the aspirin sales market.

Threats

Despite its established presence, the aspirin sales market faces several threats that could impact growth. One major concern is the increasing competition from alternative pain relief medications, such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs). These alternatives often promote fewer side effects and are marketed aggressively, making them appealing to consumers seeking pain relief. Additionally, the perception of aspirin as a one-size-fits-all solution may deter individuals from considering it for specific health needs. As consumers become more informed about their options, the market may experience a shift away from traditional aspirin products unless manufacturers effectively communicate the unique benefits of aspirin.

Another threat to the aspirin sales market is the potential for regulatory changes that may impact product formulations and labeling. Increased scrutiny over the long-term use of aspirin, particularly regarding gastrointestinal side effects, could lead to stricter regulations and affect how products are marketed. Moreover, public health guidelines may evolve, altering recommendations for aspirin use in certain populations. Companies must stay vigilant and adapt to shifting regulatory landscapes to ensure compliance and maintain consumer trust. Additionally, the rise of counterfeit medications poses a significant risk to pharmaceutical companies, potentially impacting brand reputation and consumer safety.

Competitor Outlook

• Bayer AG
• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Reckitt Benckiser Group plc
• AbbVie Inc.
• Amgen Inc.
• Hikma Pharmaceuticals PLC
• Stada Arzneimittel AG
• Alkem Laboratories Ltd.
• Dr. Reddy's Laboratories Ltd.

The overall competitive landscape of the aspirin sales market is characterized by the presence of several well-established companies, as well as emerging players looking to capture market share. Major pharmaceutical companies like Bayer AG and Pfizer Inc. have been instrumental in promoting aspirin's health benefits and expanding product lines. Bayer, for instance, has a long-standing history with aspirin and invests heavily in research and development to innovate formulations that cater to diverse consumer needs. Additionally, their strong marketing campaigns emphasize the preventive health aspects of aspirin, particularly in cardiovascular health, which resonates with consumers seeking reliable solutions for long-term health management.

In addition to the major players, the market also includes a multitude of generic manufacturers that produce affordable aspirin options. Companies like Teva Pharmaceutical Industries and Sun Pharmaceutical Industries leverage their manufacturing capabilities to offer competitive pricing, making aspirin accessible to a wider audience. The presence of both branded and generic options fosters healthy competition, driving innovation as companies strive to differentiate their products in the market. This dynamic landscape encourages continuous improvement in product quality and consumer education, enhancing the overall aspirin offering in the marketplace.

Moreover, as the market evolves, consumer preferences are shifting towards personalized healthcare solutions. Companies that can successfully adapt to these changing demands, whether through innovative formulations or targeted marketing strategies, are likely to thrive. Collaborations between pharmaceutical companies and healthcare providers are also becoming increasingly common, as they seek to educate patients about the benefits of aspirin and its various applications. This shift towards collaborative approaches enhances brand loyalty and can lead to increased sales, ultimately benefiting both the companies involved and the consumers they serve.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Bayer AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AbbVie Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novartis AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 GlaxoSmithKline plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stada Arzneimittel AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Alkem Laboratories Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hikma Pharmaceuticals PLC
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Reckitt Benckiser Group plc
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Dr. Reddy's Laboratories Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Sun Pharmaceutical Industries Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Aspirin Sales Market, By Application
    • 6.1.1 Pain Relief
    • 6.1.2 Anti-inflammatory
    • 6.1.3 Cardiovascular Protection
    • 6.1.4 Fever Reduction
    • 6.1.5 Others
  • 6.2 Aspirin Sales Market, By Product Type
    • 6.2.1 Regular Aspirin
    • 6.2.2 Enteric-coated Aspirin
    • 6.2.3 Buffered Aspirin
    • 6.2.4 Low-dose Aspirin
    • 6.2.5 Chewable Aspirin
  • 6.3 Aspirin Sales Market, By Ingredient Type
    • 6.3.1 Acetylsalicylic Acid
    • 6.3.2 Inactive Ingredients
  • 6.4 Aspirin Sales Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retailers
    • 6.4.3 Hospitals & Clinics
    • 6.4.4 Supermarkets/Hypermarkets
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Aspirin Sales Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Aspirin Sales market is categorized based on

By Product Type

• Regular Aspirin
• Enteric-coated Aspirin
• Buffered Aspirin
• Low-dose Aspirin
• Chewable Aspirin

By Application

• Pain Relief
• Anti-inflammatory
• Cardiovascular Protection
• Fever Reduction
• Others

By Distribution Channel

• Pharmacies
• Online Retailers
• Hospitals & Clinics
• Supermarkets/Hypermarkets
• Others

By Ingredient Type

• Acetylsalicylic Acid
• Inactive Ingredients

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bayer AG
• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Reckitt Benckiser Group plc
• AbbVie Inc.
• Amgen Inc.
• Hikma Pharmaceuticals PLC
• Stada Arzneimittel AG
• Alkem Laboratories Ltd.
• Dr. Reddy's Laboratories Ltd.